Skip to content

Anastomotic Techniques in Pancreaticoduodenectomy

A Randomised Controlled Trial of Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Pancreaticoduodenectomy for Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00855985
Acronym
PG/PJ
Enrollment
312
Registered
2009-03-05
Start date
2004-07-31
Completion date
2011-10-31
Last updated
2011-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer, Pancreatic Fistula

Keywords

Pancreatic anastomosis, Whipple operation

Brief summary

There are two principal ways of draining the remnant of the pancreas back into the intestine after removal of the head of the pancreas for cancer. This can be performed either to the jejunum or to the stomach. The aim of this study is to randomly allocate consenting patients to one of the two arms to study whether the leak rates from the anastomosis and the outcomes after the surgery are affected. Previous papers have shown similar results in both groups although non randomized data suggested that the Pancreaticogastrostomy (drainage into the stomach) may be superior

Interventions

PROCEDUREtype of anastomosis after pancreaticoduodenectomy

pancreaticojejunostomy (arm 1) versus pancreaticogastrostomy (arm 2)for reconstruction of the pancreatic remnant after pancreaticoduodenectomy

Sponsors

Lakeshore Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head 2. resectable tumour

Exclusion criteria

1. chronic pancreatitis/benign tumours- 2. tumours extending into the body of the pancreas 3. tumours with metastasis beyond regional lymph nodes 4. requirement for sub total pancreatectomy 5. prolonged hypotension - \< 80 mm of hg for more than 30 min

Design outcomes

Primary

MeasureTime frame
pancreatic fistula rate30 days

Secondary

MeasureTime frame
mortality90 days
Hospital stay90 days
need for postoperative intervention90 days
major complication90 days

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026